Skip to main content
OpenTrials
Completed

NCT Number: NCT02717403

Effects of Social Networking on Chronic Disease Management in Arthritis

Objectives:

The overall goal of this study is to use the principles of chronic disease management to develop and test an online social networking intervention using the FB platform in a randomized controlled trial. Our specific objectives are as follows:

Aim 1: To develop and establish an independent closed community in FB for patients with rheumatoid arthritis, providing an educational platform for disease self-management and the potential for engaging in social networking with peers (Phase 2).

Objective 1. To beta test the features and navigation buttons and panels in the newly developed website and FB group.

Objective 2. To evaluate the contents, ease of use and satisfaction with the newly developed website and FB group by patient advocates (consultants to the study) who participate as members of the Facebook community.

Aim 2: To evaluate the efficacy of the FB community intervention combined with an educational website to improve patients' self-management (including knowledge, which is the primary outcome), decision making and patient-reported outcomes compared with the educational website alone (Phase 3). We hypothesize that participation in an online closed community offering evidence-based information combined with peer interaction and support will improve patients' knowledge.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Disease Management Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Rheumatoid Arthritis Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

Pilot Testing Phase:

Five participants will be recruited to pilot test and give feedback on the control educational website and the FB community. Participants will have access to the educational website and FB, for a period of one week. The main purpose is to test ease of use and satisfaction with both platforms. After 1 week, research staff will call the participant to obtain feedback about the websites. The interview will last approximately 30 minutes and in the case the participant does not finish the interview, the investigators will conduct a follow-up phone interview.

Randomization Phase:

Participants will complete a self response electronic questionnaire at baseline. Participants then randomized into one of two arms: Intervention (FB + Website) and Control (Website alone). The participant will be shown how to access the website and the Facebook page on the internet about rheumatoid arthritis. Patients will be assessed at three and six months after baseline via email self response electronic questionnaires. This phase will recruit 220 participants.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older (usability test and RCT)
  • Staff of the Department of General Internal Medicine (usability test)
  • Diagnosis of rheumatoid arthritis by a rheumatologist (RCT)
  • Ongoing or prior treatment with traditional disease-modifying anti-rheumatic drugs or biologic agents (RCT)
  • Adequate cognitive status as determined by a research coordinator at recruitment. To assess the participant's capacity to take part in the interview, the interviewer will note and comment on the participant's spontaneous speech and capacity to write date at the time of consent. Participants should be oriented to person, place, date, time, and events (RCT)
  • Living in the community (not institutionalized, etc. ) (RCT)
  • Able to communicate in English (RCT)
  • Use internet on average at-least once a week (RCT);
  • Disease duration 10 years or less (RCT)
  • Familiarity with and participation in social media (e.g. Facebook) (usability test and RCT)

Exclusion criteria

  • Participants not willing to complete interviews or survey instruments (usability test and RCT)
  • Hospitalized (RCT)
  • Patients who do not verbally, written, or electronically consent to participate (usability test and RCT)

Treatment and study plan

Questionnaires

Behavioral

Participants complete a self response electronic questionnaire at baseline, and at three and six months.

Other names: Surveys

Facebook

Behavioral

Participant accesses Facebook page regarding rheumatoid arthritis.

Other names: Social Media

Educational website

Behavioral

Participant accesses Educational Website on the internet about rheumatoid arthritis.

Phone Interview

Behavioral

Research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.

Primary outcomes

  1. Participant Knowledge of Rheumatoid Arthritis assessed with the Patient Knowledge Questionnaire (PKQ-RA)

    Time frame: 6 months

    The Patient Knowledge Questionnaire (PKQ-RA) will measure this outcome.

Secondary outcomes

  1. Control in Health Care Decisions assessed with the Control Preferences Scale (CPS-RA)

    Time frame: 6 months

    The Control Preferences Scale (CPS-RA) used to measure the degree of control an individual wants to assume while making decisions about their health care.

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • Rheumatology Research Foundation

Registry information

Official study title

Phase 2 & Phase 3, Effects of Social Networking on Chronic Disease Management in Arthritis

Important dates

Study start
2016
Primary completion
2023
Study completion
2023
First posted
Mar 23, 2016
Registry last updated
Jun 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.